ATAyşe Tosun

Ayşe Tosun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayşe Tosun has a total of 281 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Research on soft neurological signs obese children

    by Tuğba Doğanç, Elif Çelik, Ahmet Anık, Ayşe Tosun

    Objective: Soft neurological signs (SNS) are subtle indicators detected during neurological examination in the absence of an overt neurological disorder. This study aimed to investigate the presence of SNS in obese children. Methods: A total of 61 obese children and 57 healthy controls (HCs) were evaluated using the Neurological Evaluation Scale (NES) to assess the presence of SNS. Results: There were no significant differences between the obese and HC groups regarding age and sex (p>0.05). The sensory integration, motor coordination, complex sequential motor acts, other NES, and total NES scores were significantly higher in the obese group compared with HCs (p=0.005, p=0.009, p=0.004, p=0.002, and <0.001, respectively). Conclusion: This is the first study to demonstrate a significant presence of SNS in obese children using the NES. Incorporating SNS assessment into routine obesity evaluations may help identify children at risk for early neurodevelopmental changes.

  • Neonatal-onset genetic epilepsies: Insights from a large multicentre cohort

    by Gunce Basarir, Pınar Gençpınar, Sema Bozkaya Yılmaz, Berk Özyılmaz, Nihal Olgaç Dündar, Dilşad Türkdoğan, Sermin Özcan, Hamza Polat, Burcu Karakayalı, Gülten Öztürk, et al.


  • Two Siblings With Al Kaissi Syndrome: Clinical, Radiological, and Molecular Characterization of Compound Heterozygous CDK10 Variants

    by Zehra Manav Yigit, Aydan Mengubas Erbas, Ridvan Savas, Ayse Tosun, Goksel Tuzcu, Gokay Bozkurt

    Al Kaissi syndrome is a rare autosomal recessive neurodevelopmental disorder resulting from biallelic loss‐of‐function variants in the CDK10 gene. Cyclin‐dependent kinase 10 (CDK10) encoded protein plays essential roles in cell cycle regulation, transcriptional control, and ciliogenesis. We report two male siblings presenting with developmental delay, dysmorphic facial features, and skeletal anomalies. Comprehensive clinical, radiological, and molecular genetic evaluations were performed on the affected individuals and their parents, including exome sequencing. Both siblings were found to carry compound heterozygous pathogenic variants in CDK10 : a previously reported splice‐site variant (c.609‐1G > A) and a frameshift variant (c.520_521del), previously unreported in clinical cases. The clinical phenotype in both cases was consistent with Al Kaissi syndrome, including intellectual disability, facial dysmorphisms, spinal malformations, and delayed developmental milestones. This report presents the first Turkish cases of Al Kaissi syndrome with compound heterozygous CDK10 variants and thoroughly reviews previously reported cases. This expands the known phenotypic and genotypic spectrum of the disorder.

  • Open Access

    Using audiovisual intervention to reduce anxiety and improve image quality in pediatric magnetic resonance imaging

    by Seçil Oktay, Türker Söğütlüler, Sibelnur Avcil, Ceren Akçanal Şeker, Hatice Öner, Hakan Öztürk, Ayşe Tosun, Yelda Özsunar

    Background: Magnetic resonance imaging (MRI) is a crucial diagnostic modality for pediatric patients because it avoids ionizing radiation. However, the confined space and loud noises inherent to MRI can trigger anxiety in children, potentially compromising their cooperation and image quality. Objective: To evaluate the effectiveness of an audiovisual preparatory intervention in reducing anxiety and improving MRI image quality in children. Materials and methods: In this randomized controlled trial, 48 children aged 7–11 years referred for MRI were randomly assigned to either an experimental group (n=24) or a control group (n=24). The experimental group viewed a child-friendly preparatory film prior to the MRI. Anxiety was assessed using the State-Trait Anxiety Inventory for Children before and after MRI. Image quality was evaluated independently by blinded radiologists using standardized scoring criteria. Results: There were no significant differences in baseline state anxiety (P=0.790) or trait anxiety (P=0.414) between groups. Post-MRI state anxiety scores were significantly lower in the experimental group (31.17±8.78) compared to the control group (37.90±6.51; P=0.004). Post-MRI trait anxiety scores remained statistically similar (P=0.491). Image quality scores were significantly higher in the experimental group than in the control group (P=0.005). Conclusion: Audiovisual preparatory interventions significantly reduce state anxiety and enhance image quality in pediatric MRI without affecting trait anxiety. These findings support the integration of non-pharmacological, child-centered preparatory tools into routine MRI protocols to improve patient cooperation and diagnostic outcomes. Graphical


  • Open Access

    Phenotypic variability in cases with CACNA1A mutation

    by Sema Bozkaya-Yilmaz, Nihal Olgac-Dundar, Nargiz Aliyeva, Atilla Ersen, Pinar Gencpinar, Mesut Gungor, Ayse Semra Hiz, Uluc Yis, Gamze Sarikaya-Uzan, Esra Sarigecili, et al.

    The purpose of this study was to enhance understanding of CACNA1A gene variants by elucidating the clinical profiles of patients with different variants. The overlapping features and varying phenotypic characteristics of these neurological disorders pose challenges for clinicians. A data collection form was utilized to gather clinical features, examination details, and treatment information associated with CACNA1A variants. Thirty-one patients were included in the study from 11 different clinics in Turkey. Cases were assessed by comparing their information with existing literature. The study initially included 32 patients from 29 families, with 31 patients meeting the inclusion criteria. Clinical manifestations ranged from congenital onset hypotonia to motor seizures. Within the group of patients, 87% were diagnosed with epilepsy, 61% had neurodevelopmental defects, 32% experienced ataxia, 22% had eye movement problems, 16% suffered from migraines, and 13% had recurrent encephalopathy. Thirty percent of individuals exhibited cerebellar atrophy. A subset of individuals exhibited various forms of cognitive impairment and different kinds of ataxia. Conclusion: CACNA1A variants can lead to structural and functional abnormalities in the Cav2.1 channels, resulting in paroxysmal and/or chronic clinical presentations. The overlapping phenotypes and variable features among family members suggest the influence of environmental factors and modifier genes. A thorough understanding of the range of phenotypic variants and the difficulties encountered by medical professionals is essential for precise diagnosis and efficient treatment approaches in various neurological conditions. Additional research is necessary to clarify the underlying mechanisms that contribute to the various presentations of these variants. What is known: • Variants in the CACNA1A gene disrupt calcium signaling, thereby impacting fundamental developmental processes such as neuronal differentiation, migration, and synapse formation. • Variants in the CACNA1A can lead to neurodevelopmental disorders characterized by intellectual disability, learning difficulties, memory challenges, and problems in social interaction. What is new: • Instances of intrafamilial variability in CACNA1A variants have been identified, with differing clinical manifestations exhibited by affected family members. • Incomplete penetrance is a phenomenon that may occur, as neurodevelopmental or neuropsychiatric findings are not exhibited by some patients with CACNA1A variants.


  • Open Access

    Reviewing the reliability of revised Melbourne Cerebral Palsy Hip Classification System across different medical specialties

    by Mustafa Gok, Ridvan Oner, Ferit Tufan Ozgezmez, Elif Aydin, Ayse Fahriye Tosun, Emre Cullu

    Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.

  • Etiyolojiye Spesifik Epilepsi Sendromları

    by Hande Gazeteci Tekin, Pakize Karaoğlu, Ayşe Tosun

  • Open Access

    Canpolat, Temel Pediatrik Epilepsi

    by Yiğithan Güzin, Aycan Ünalp, Semra Büyükkorkmaz Öztürk, Müge Ayanoğlu, Fatma Hancı, Esma Şengenç, Sema Saltık, Hatice Hilal Kırkgöz, Burcu Karakayalı, Dilşad Türkdoğan, et al.

  • Retracted: Clinical and genetic evaluations of rare childhood epilepsies in Turkey's national cohort

    by Aycan Ünalp, Yiğithan Güzin, Bülent Ünay, Ayşe Tosun, Dilek Çavuşoğlu, Hande Gazeteci Tekin, Semra Hız Kurul, Ebru Arhan, Selvinaz Edizer, Gülten Öztürk, et al.

    As new-generation sequencing methods develop, rare epilepsy is increasing and burdening national health systems-community building among rare epilepsies fuels collaboration, research, and resource development. Comorbidities should be carefully considered in diagnosing and treating children with rare epilepsy. This multicentric study aimed to evaluate the clinical features and comorbidities of children diagnosed with rare childhood genetic epilepsies. This multicentric study evaluated demographics, clinical findings, neuromotor developmental progress, and concomitant comorbid diseases of childhood rare genetic epilepsies. We included 156 patients from the nine tertiary health centers in our research. The gene variants were distributed to 36 patients (23,1%) with SCN1A, 14 (9%) with KCNQ2, 10 (6,4%) with PCDH19, 6 (3,8%) with SCN8A, 5 (3,2%) with SLC2A1, 5 (3,2%) with WWOX, respectively. The remaining 80 patients (51,3%) were with other gene variants. Comorbid conditions are present in 82% of patients, most commonly intellectual disability (70%), developmental delay (32.1%), and movement disorders 12.8%. Most of the rare genetic epileptic children (52%) were using more than 3 anti-seizure drugs. In terms of developmental delay in children with rare epilepsy, the neuromotor developmental delay was found to progress with age, shown at the end of 2nd year of treatment. In addition, comorbidity, number of drugs, multiple types of seizures, seizure frequency, age at diagnosis of epilepsy, and duration of epilepsy all affected neuromotor developmental status (P<0.05). Despite using multiple antiseizure medications, most of our patients had drug-resistant epilepsy and concomitant developmental delay. Since a complete cure cannot be achieved in most of these patients further studies with centers' collaboration might help improve therapeutic decisions and precision treatment methods.